Data as of Apr 17
| +0.40 / +0.40%|
The 15 analysts offering 12-month price forecasts for Salix Pharmaceuticals Ltd have a median target of 126.00, with a high estimate of 135.00 and a low estimate of 103.00. The median estimate represents a +24.68% increase from the last price of 101.06.
The current consensus among 16 polled investment analysts is to Buy stock in Salix Pharmaceuticals Ltd. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.